GlassScriptPhysician profile
Wade Naziri
NPI 1760431613
$15,167.34
in general payments reported to CMS, 2019-2025
30 companies · $964 in 2025
The $964 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,374 · 2020: $225 · 2021: $160 · 2022: $147 · 2023: $428 · 2024: $12K · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $4,091 · Food and Beverage: $2,162 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $4,090.85 |
| Food and Beverage | $2,161.94 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,228.67 | 2022-2025 | |
| Covidien LP | $1,255.66 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $262.36 | 2019-2024 | Nascobal |
| Medtronic, INC. | $223.25 | 2023-2024 | Ligasure |
| Teleflex LLC | $221.84 | 2020-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Davol INC. | $119.47 | 2019-2024 | Phasix Mesh |
| Novo Nordisk INC | $114.34 | 2019-2025 | Wegovy |
| Ethicon US, LLC | $104.34 | 2019-2024 | Linx Reflux Management System, Echelon; Endopath, Monocryl |
| Merck Sharp & Dohme LLC | $66.62 | 2020-2025 | Bridion, Dificid |
| Phathom Pharmaceuticals, INC. | $62.56 | 2024-2025 | Voquezna |
| Intra-Sana Laboratories | $56.65 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Baxter Healthcare | $49.06 | 2019 | |
| Lilly USA, LLC | $48.84 | 2024 | Zepbound, Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $38.22 | 2023 | Gattex, Entyvio |
| Regeneron Healthcare Solutions, INC. | $32.36 | 2025 | Dupixent |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $26.28 | 2024 | |
| Pharmacosmos Therapeutics INC. | $24.84 | 2023 | Monoferric |
| Smith+Nephew, INC. | $22.73 | 2024 | Stravix, Grafix Pl |
| Hologic Sales and Service, LLC | $20.49 | 2024 | Coolseal Generator |
| Karl Storz Endoscopy-America | $19.32 | 2019 | |
| Nestle Healthcare Nutrition INC. | $19.12 | 2021 | |
| Trevena, INC. | $18.83 | 2021 | |
| Ardelyx, INC. | $18.78 | 2023 | Ibsrela |
| Fresenius Kabi USA, LLC | $18.06 | 2023 | Idacio |
| Glaxosmithkline, LLC. | $17.86 | 2024 | Arexvy |
| Integra Lifesciences Corporation | $17.59 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.23 | 2023 | Cyltezo |
| Vivus LLC | $15.77 | 2022 | |
| Pfizer INC. | $13.75 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.45 | 2023 | Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Naziri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.